JP Morgan Chase’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

JP Morgan Chase’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,400	Closed	-$51K	–	6955
2022 Q2	$51K	Buy	+1,400	New	+$50.9K	﹤0.01%	5653

Other funds holding SILK

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

JP Morgan Chase's SILK Position: Q3 2024 in Review

JP Morgan Chase sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 34,869 shares — an estimated $943K sold.

JP Morgan Chase first reported a position in SILK in Q2 2019 and held it in 21 quarters. The position peaked at $8.04M in Q1 2023. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

JP Morgan Chase reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
JP Morgan Chase sold 34,869 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $943K.
JP Morgan Chase first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 21 quarters.
JP Morgan Chase's Silk Road Medical, Inc. Common Stock position peaked at $8.04M in Q1 2023.
1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on JP Morgan Chase's 13F filing for Q3 2024, filed 8 Nov 2024.